The information provided in this website should not be construed as an offer to sell to any person, or a solicitation of any offer to buy from any person, in any jurisdiction, any interests in any products or funds, nor should it be regarded as an investment product or financial advice or be relied upon for any purpose.

While CLSA Capital Partners Limited, its subsidiaries and their respective directors, officers, employees, agents, contractors and advisers (collectively, the "CLSA Capital Partners Group") use reasonable efforts to obtain information from sources believed to be reliable, the CLSA Capital Partners Group does not make any representation or warranty as to the truth, accuracy or completeness of the information (including statements of opinion or expectation) provided in this website or as to the achievement or reasonableness of any future projections, estimates, prospects or returns or any of the assumptions underlying them. The CLSA Capital Partners Group shall not have any liability (whether arising from negligence or otherwise) for any representations (expressed or implied) contained in, or for any omissions from, the information on this website. None of the information provided in this website has been approved by any governmental or other authority in any jurisdiction.

The investments described in this website were selected to illustrate types of investments that the funds sponsored by the CLSA Capital Partners Group may pursue. Therefore, these investments are not indicative of future investments or the actual or anticipated performance of the funds, sponsored by the CLSA Capital Partners Group, through which such investments were made, nor should such investments be viewed as representative of the portfolio of investments held by such funds.

The content provided in this website is, unless otherwise specified, directed at residents of the United States and not intended for distribution to, or use by, any person or entity in any jurisdiction where such distribution or use would be contrary to law or regulation or which would subject the CLSA Capital Partners Group to any registration or other requirement within such jurisdiction. Access to this website may be limited with respect to any person, geographic region or jurisdiction, and the information contained in this website is subject to change without notice.


In accordance with the Financial Instruments and Exchange Law of Japan, certain information is made available for Japanese investors upon request. Please email us at Capital.Partners@clsa.com.


当サイトに掲載しているCLSA Capital Partners Limitedの運用するファンド(以下「ファンドという。」)に関する情報は、投資に対する助言または販売の勧誘を目的としたものではありません。またこれらの情報は特定の金融商品等の売買の推奨又は投資助言を意図したものではありません。



Baifeng Hu
Head of CLSA Capital Partners

Mr. Hu is Head of CLSA Capital Partners, the global alternative investment platform of CITIC Securities. He joined CITIC Securities in May 2014, and served in its onshore alternative investment platform Goldstone Investment Co., Ltd, as Deputy General Manager and Member of Investment Committee, and heads CITIC M&A Fund, the flagship PE fund of CITIC Securities.

Mr. Hu brings over 18 years of experience in M&A and investment. He has led and closed numerous private equity deals in healthcare, TMT, and high-end manufacturing sectors, and is equipped with rich knowledge in investment, fund management and corporate leadership. Prior to joining CITIC Securities, Mr. Hu served as Head of Investment Division II and Member of Investment Committee in CDB Capital.

Mr. Hu holds leadership positions in top players of various strategically-important industries. Currently he is the Chairman of Ampleon, a global-leading semiconductor company headquartered in Netherland, and Director of Pharmaron, a top-5 CRO company in the world.

Deborah Feng
Head of Strategy & Business Development and Executive Director, Private Equity

Ms. Feng has over 12 years of experience in private equity investment, portfolio management and investment banking in Greater China. She joined CLSA Capital Partners in 2019, while serving as Director of Healthcare Investment Department in Goldstone.

Joining Goldstone in 2016, Ms. Feng participated in a considerable number of private equity deals in healthcare and TMT sector. Prior to joining Goldstone, she worked for the Investment Banking Division of Zhong De Securities (China joint venture established by Deutsche Bank) for more than 6 years, and completed various corporate finance deals including IPOs, M&A and follow-on offerings. Ms. Feng holds a bachelor’s degree in international economics and commerce from Zhejiang University and a master’s degree in economics from Baylor University Hankamer School of Business. Ms. Feng holds China A-share Sponsor Representative Qualification equivalent.

Amy Jia
Director, Credit Business

Ms. Jia has over 9 years of private equity investment and business start-up experience in Greater China. She joined CLSA Capital Partners in 2019, while serving as SVP of Healthcare Investment Department in Goldstone.

Joining Goldstone in 2016, Ms. Jia participated in a considerable number of private equity deals in healthcare and TMT sector. Prior to joining Goldstone Investment, she was the co-founder and CEO of China Loyalty Fine Wines Limited, a cross-border trading platform incorporated in Hong Kong. Ms. Jia holds a bachelor’s degree in engineering from University of Hong Kong and a MBA degree from New York University Stern School of Business. She is also a CFA Charterholder.

Derek Hung
Managing Director, Head of Transaction Management

Mr. Hung currently serves as Managing Director, Head of Transaction Management of CLSA Capital Partners. He has over 15 years of experience in private equity investments and law in Asia and is legally qualified in England & Wales, New South Wales and Hong Kong. He joined CLSA Capital Partners in 2021.

Previously he was the General Counsel at China-ASEAN Fund, the Assistant Head of Legal at CCB International and a Senior Associate at Clifford Chance. Mr. Hung holds undergraduate degrees in commerce and in law from the University of New South Wales.

Doris Lee
Head of Finance

Ms. Lee has been with CLSA for 14 years, with vast experience from various departments within the organization. She is currently responsible for providing managerial, financial and governance oversight to more than 13 different private equity, real estate, debt, special situation funds and principal investment strategies across Asia and Europe. Prior to that, she was Head of Finance – Private Investments and Asset Management providing leadership and direction on financial activities of corporate entities for private equity funds, hedge funds, separately managed accounts and fund administration services.

Before joining CLSA, Ms. Lee took up different roles in Instinet, Ernst & Young and Standard Chartered Bank. She holds a bachelor’s degree of commerce from University of Manitoba (Dean’s Honour List), and is a member of HKICPA, CPABC, AICPA and CGMA.

Nick Chiu
Director, Operations

Mr. Chiu currently serves as Operations Director of CLSA Capital Partners. He has over 13 years of experience in the financial services industry.

Before he joined CLSA Capital Partners, Mr. Chiu was the Head of Compliance of Taikang Asset Management in Hong Kong, overseeing regulatory compliance matters including AML/CFT and KYC programs. Mr. Chiu was a Manager in the Intermediaries Supervision Department of the SFC before he joined Deutsche Bank Asset Management as a Compliance Manager.

Prior to that, he was an Audit Manager with KPMG Financial Services Hong Kong and a Compliance and Regulatory Executive at Deacons. Mr. Chiu holds an undergraduate degree in BBA Accounting and Finance from the University of Hong Kong and is a Certified Public Accountant in Hong Kong.